Christopher Starr, Director at Raptor Pharmaceutical Corp., holds 15.05K shares in Monopar Therapeutics Inc (Ticker: MNPR), holds 706.07K shares in Raptor Pharmaceutical Corp. (Ticker: RPTP). Most recently, Christopher Starr Sold ― shares of Monopar Therapeutics Inc on Jul 16, 2025 for an estimated value of 672.00K.
What is the percentage of profitable transactions made by Christopher Starr?
The percentage of profitable transactions made by Christopher Starr is ―.
What is the average return per transaction made by Christopher Starr?
The average return per transaction made by Christopher Starr is ―.
What stocks does Christopher Starr hold?
Christopher Starr holds: RPTP, MNPR stocks.
What was Christopher Starr’s latest transaction?
Christopher Starr latest transaction was an Informative Sell of $672.00K.
What was Christopher Starr's most profitable transaction?
Christopher Starr’s most profitable transaction was an Informative Sell of MNPR stock on July 16, 2025. The return on the trade was -9.40%.
What is Christopher Starr's role in Raptor Pharmaceutical Corp.?
Christopher Starr's role in Raptor Pharmaceutical Corp. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.